Skip to main content

Advertisement

Table 1 Clinical features of all participants in the chronic sugar-sweetened beverage intake urate analysis

From: Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout

  Percentage with data All (n = 12,870) BMI <25 (n = 5,002) BMI ≥25 (n = 7,862) P
Age, years 100 49.5 (10.1) 48.9 (10.4) 49.9 (9.9) 9 × 10−9*
Male sex, n (%) 100 6030 (46.9) 1740 (34.8) 4288 (54.5) <1.0 × 10−5**
NZ East Polynesian dataset, n (%) 100 583 (4.5) 96 (1.9) 487 (6.2) <1.0 × 10−5**
NZ West Polynesian dataset, n (%) 100 271 (2.1) 16 (0.3) 255 (3.2)
NZ Mixed East/West Polynesian dataset, n (%) 100 64 (0.5) 4 (0.1) 60 (0.8)
NZ Caucasian dataset, n (%) 100 450 (3.5) 152 (3.0) 298 (3.8)
ARIC Caucasian dataset, n (%) 100 6927 (53.8) 2930 (58.6) 3996 (50.8)
FHS Caucasian dataset, n (%) 100 3066 (23.8) 1380 (27.6) 1686 (21.4)
ARIC African American dataset, n (%) 100 1509 (11.7) 424 (8.5) 1080 (13.7)
Serum urate, mmol/L 98.4 0.33 (0.09) 0.30 (0.07) 0.36 (0.08) <1.0 × 10−300*
Triglycerides, mmol/L 98.0 1.79 (1.52) 1.45 (1.04) 2.01 (1.72) <1.0 × 10−300*
Body mass index, kg/m2 99.9 27.1 (5.4) 22.4 (1.8) 30.1 (4.8) <1.0 × 10−300*
Fruit intake, pieces/day 99.8 1.47 (1.31) 1.45 (1.32) 1.48 (1.31) 0.32*
Kidney disease, n (%) 96.3 134 (1.1) 34 (0.7) 100 (1.3) 1.4 × 10−3**
Hypertension, n (%) 99.3 1541 (12.1) 395 (7.9) 1143 (14.7) <1.0 × 10−5**
  1. Unless specified, data are presented as mean (SD)
  2. BMI body mass index, NZ New Zealand, ARIC Atherosclerosis Risk in Communities, FHS Framingham Heart Study
  3. *Two-sample t test with unequal variances
  4. **Chi-square test